Robert Tepper Net Worth & Insider Trades

Robert Tepper Jounce Therapeutics, Inc

As of November 16, 2021

What is Robert Tepper's Net Worth?

The current estimated net worth of Jounce Therapeutics, Inc's Robert Tepper is estimated to be about $1.4B . Robert Tepper owns about 1,432,638 units of Jounce Therapeutics, Inc common stock. In the last 4 years at Jounce Therapeutics, Inc, Robert Tepper has sold an estimated value of $37.59M worth.

What is Robert Tepper's Past Insider Trading?

Robert Tepper's largest sale order was 1,450,000 units , worth over $17.04M on March 3, 2021. In total, Robert Tepper has made about 13 transactions over 4 years of their time at Jounce Therapeutics, Inc. Robert Tepper usually trades in June and November, with the busiest year in 2021. The most recent transaction was a sale order of 1,900,000 units , worth over $15.92M on November 16, 2021.

Third Rock Ventures III LP, Third Rock Ventures GP III LP, TRV GP III LLC, KEVIN STARR, ROBERT TEPPER, MARK LEVIN

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Robert Tepper's' Mailing Address?

  • Mailing address is 29 Newbury Street 3rd Floor Boston MA 02116 MA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

What are Jounce Therapeutics, Inc's Past Insider Trades?

Jounce Therapeutics, Inc's most recent insider trade came on January 11, 2022 by Elizabeth Trehu who sold 8,383 units worth $57.7K . In the last 5 years, insiders at Jounce Therapeutics, Inc have sold an estimated value of $42.43M and bought an estimated value of $10.7M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Ca Richard Murray, CEO and President .

Jounce Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1